Innovative Treatment Platform Amplitude Vascular Systems has developed the Pulse IVL System, a novel pulsatile intravascular lithotripsy device that effectively shatters calcium in severely calcified arterial lesions, highlighting an advanced technological solution that differentiates it in the medical device market.

Strong Funding Momentum The company has secured significant Series B funding across multiple rounds, accumulating over $65 million, indicating robust investor confidence and validating the market potential for its innovative vascular treatment technology.

Expanding Leadership Team Recent appointment of a Vice President of Clinical Affairs underscores AVS's focus on clinical validation and building a strong medical background, making it more attractive to healthcare providers and potential partners seeking proven, reliable solutions.

Market Focus and Growth As an early-stage, Boston-based medical device company targeting severe arterial calcification, AVS presents a compelling sales opportunity to hospitals and interventional clinics seeking advanced minimally invasive tools for complex vascular interventions.

Digital Presence and Security The company’s use of advanced web technologies such as Cloudflare and CDNjs reflects a focus on strong digital infrastructure, which facilitates marketing, communication, and customer engagement efforts essential for expanding sales reach.